Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of BMP2 on B16F10 melanoma cells

ABSTRACT: Effect of BMP2 on B16F10 melanoma cells

PROVIDER: PRJNA481005 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Effect of BMP2 on B16F10 melanoma cells

Project description:BMP2 treatment significantly reduces growth of B16F10 melanoma spheroids. This experiment analyses the transcriptome changes in B16F10 cells treated with or without BMP2.

2019-01-01 | GSE117074 | GEO

RNAseq of B16F10 melanoma CD31+ cells

Project description:RNAseq of B16F10 melanoma CD31+ cells

| PRJNA606295 | ENA

Immunostimulatory effect of senescence in B16F10 melanoma cells

Project description:To investigate the effect of senescence induction on immunogical signatures in immunosuppresive B16F10 cells treated with the senescence inducer Doxorubicin

2022-10-18 | GSE212112 | GEO

Expression data from SQ-diEG treated B16F10 cells

Project description:Global gene expression profiling reveals a potential anti-melanoma effect of SQ-diEG in B16F10 cells. Squalene (SQ) was considered as a promising natural agent in anti-cancer treatment due to its strong antioxidant and anti-inflammatory activity; however, its pharmacological value has been largely underestimated because of its poor solubility and bioavailability. To adress this problem, a novel amphiphilic SQ derivative which bearing ethylene glycol oligomers was synthesized and was used as a permeation enhancer in this study to check its potential effect on anti-melanoma using B16F10 cells B16F10 were murine melanoma cells line, treated with 2.5 µM and 40 µM with all samples for 48 h. Microarray gene expression profiling was conducted for two biological replicates

2023-02-06 | GSE224256 | GEO

RNA-Seq analysis of isolated myeloid cells and melanoma cells, B16F10 and YUMM3.3.

Project description:We evaluated the changes in the transcriptome of spleen and bone marrow isolated myeloid cells in healthy and melanoma bearing animals and melanoma cell lines, B16F10 and YUMM3.3 using RNA-sequencing technologies.

2023-02-15 | GSE215005 | GEO

Effect of SIRPA perturbation on transcriptome of B16 murine melanoma cells

Project description:To explore the effect of SIRPA perturbation on the expression changes of melanoma differentiation antigens (MDA), which directly mediates the immunogenicity of melanoma cells, we profiled the transcriptomes of B16F10 cells with SIRPA knockdown, overexpression, or control.

2022-08-18 | GSE211226 | GEO

The effect of TIM-3 stimulation on the gene expression profile of B16-F10 melanoma cells

Project description:The effect of TIM-3 stimulation was studied on B16F10 mouse melanoma cells, in vitro.

2009-10-01 | GSE14418 | GEO

RNAseq of B16F10 melanoma CD31+ cells

Project description:Intravasation, vascular dissemination and metastasis of malignant tumor cells require their passage over the vascular wall which is commonly composed of pericytes (mural cells) and the endothelial cell barrier. We currently decided to investigate the relative contribution of these cell types for B16F10 melanoma metastasis in mice using an experimental model of Shb gene inactivation. RNAseq of tumor endothelial cells from these mice revealed changes in cellular components such as adherens junctions and focal adhesions by gene ontology analysis that were in line with the observed effects on leakage and junction morphology.

2020-05-18 | GSE145201 | GEO

Transcriptional changes induced by Lamin A/C downregulation in the nuclei of B16F10 melanoma cells

Project description:Major transcriptional changes (300 differentially expressed genes) take place upon downregulation of Lamin A/C in B16F10 melanoma cells

2021-06-02 | GSE146730 | GEO

Transcription profiling of mouse B16-F10 melanoma cells stimulated with TIM-3

Project description:The effect of TIM-3 stimulation was studied on B16F10 mouse melanoma cells, in vitro. Experiment Overall Design: Cy3: B16F10 mouse melanoma cells, treated by unspecific goat IgG (control) for 2 hours. Experiment Overall Design: Cy5: B16F10 mouse melanoma cells, in vitro, treated by an agonist goat polyclonal anti-mouse TIM3 antibody (RnD Systems) for 2 hours. Experiment Overall Design: Four biological replicates were used (in this study, biological replicate means different passage numbers of the same cell line). In each case, the treated sample (Cy5) was compared to its control one (Cy3) in Agilent dual-color microarray experiments.

2009-10-15 | E-GEOD-14418 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data